Epstein?Barr virus?related lymphoproliferative disorders in T?cell repleted haploidentical transplantation with post?transplant cyclophosphamide
dc.authorid | Vedat Uygun / 0000-0003-3257-7798 | en_US |
dc.authorscopusid | Vedat Uygun / 10043117000 | |
dc.authorwosid | Vedat Uygun / AGH-4534-2022 | |
dc.contributor.author | Uygun, Vedat | |
dc.contributor.author | Özsan, Nazan | |
dc.contributor.author | Daloğlu, Hayriye | |
dc.contributor.author | Öztürkmen, Seda | |
dc.contributor.author | Yalçın, Koray | |
dc.contributor.author | Karasu, Gülsün | |
dc.contributor.author | Yeşilipek, Akif | |
dc.date.accessioned | 2021-11-30T05:28:09Z | |
dc.date.available | 2021-11-30T05:28:09Z | |
dc.date.issued | 2021 | en_US |
dc.department | İstinye Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü | en_US |
dc.description.abstract | EBV-associated lymphoproliferative disorders (LPDs) are common in hematopoietic stem cell transplantation (HSCT) with T-cell-depleted grafts, but are extremely rare in HSCT patients with T-cell-replete grafts with post-transplant cyclophosphamide (PTCy). Here we present the cases of two pediatric patients who developed EBV-related LPD after T-cell-replete haplo-HSCT with PTCy. One of these is the first reported case of EBV-positive mucocutaneous ulcer (EBVMCU) developing after PTCy. EBV-related diseases are rare in T-cell-replete haplo-HSCT patients with PTCy. However, in patients with risk factors, it is reasonable to screen for EBV viremia for LPD. | en_US |
dc.identifier.citation | Uygun, V., Özsan, N., Daloğlu, H., Öztürkmen, S., Yalçın, K., Karasu, G., & Yeşilipek, A. (2021). Epstein-Barr virus-related lymphoproliferative disorders in T-cell repleted haploidentical transplantation with post-transplant cyclophosphamide. International journal of hematology, 10.1007/s12185-021-03267-8. Advance online publication. | en_US |
dc.identifier.doi | 10.1007/s12185-021-03267-8 | en_US |
dc.identifier.pmid | 34826107 | en_US |
dc.identifier.scopus | 2-s2.0-85119955552 | en_US |
dc.identifier.scopusquality | N/A | en_US |
dc.identifier.uri | https://doi.org/10.1007/s12185-021-03267-8 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12713/2288 | |
dc.identifier.wos | WOS:000722865400001 | en_US |
dc.identifier.wosquality | Q3 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.indekslendigikaynak | PubMed | en_US |
dc.institutionauthor | Uygun, Vedat | |
dc.language.iso | en | en_US |
dc.publisher | Springer Link | en_US |
dc.relation.ispartof | International Journal of Hematology | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | EBV-positive Mucocutaneous Ulcer | en_US |
dc.subject | Epstein–Barr Virus | en_US |
dc.subject | Lymphoproliferative Disorder | en_US |
dc.subject | Post-transplant Cyclophosphamide | en_US |
dc.title | Epstein?Barr virus?related lymphoproliferative disorders in T?cell repleted haploidentical transplantation with post?transplant cyclophosphamide | en_US |
dc.type | Article | en_US |